Insider Transactions in Q1 2022 at Alkermes Plc. (ALKS)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 04
2022
|
Nancy Lynn Md Snyderman Director |
BUY
Open market or private purchase
|
Direct |
427
+4.36%
|
$9,821
$23.43 P/Share
|
|
Feb 23
2022
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
11,983
-39.97%
|
$287,592
$24.76 P/Share
|
|
Feb 22
2022
|
Iain Michael Brown SVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,049
-3.31%
|
$51,225
$25.01 P/Share
|
|
Feb 22
2022
|
Iain Michael Brown SVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,969
+10.11%
|
-
|
|
Feb 22
2022
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
2,143
-2.15%
|
$53,575
$25.01 P/Share
|
|
Feb 22
2022
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
7,286
+6.8%
|
-
|
|
Feb 22
2022
|
Blair Curtis Jackson EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,794
-3.08%
|
$69,850
$25.01 P/Share
|
|
Feb 22
2022
|
Blair Curtis Jackson EVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,503
+9.48%
|
-
|
|
Feb 22
2022
|
Michael J Landine SVP, Corp Dev., Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
2,462
-1.05%
|
$61,550
$25.01 P/Share
|
|
Feb 22
2022
|
Michael J Landine SVP, Corp Dev., Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
5,543
+2.31%
|
-
|
|
Feb 22
2022
|
Christian Todd Nichols SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,041
-7.27%
|
$51,025
$25.01 P/Share
|
|
Feb 22
2022
|
Christian Todd Nichols SVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,969
+19.88%
|
-
|
|
Feb 22
2022
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,539
-10.56%
|
$88,475
$25.01 P/Share
|
|
Feb 22
2022
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,037
+26.42%
|
-
|
|
Feb 21
2022
|
Iain Michael Brown SVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,412
-2.5%
|
$35,300
$25.08 P/Share
|
|
Feb 21
2022
|
Iain Michael Brown SVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,800
+7.84%
|
-
|
|
Feb 21
2022
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
2,022
-2.14%
|
$50,550
$25.08 P/Share
|
|
Feb 21
2022
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
6,875
+6.77%
|
-
|
|
Feb 21
2022
|
Blair Curtis Jackson EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,412
-1.71%
|
$35,300
$25.08 P/Share
|
|
Feb 21
2022
|
Blair Curtis Jackson EVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,800
+5.49%
|
-
|
|
Feb 21
2022
|
Michael J Landine SVP, Corp Dev., Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
2,587
-1.12%
|
$64,675
$25.08 P/Share
|
|
Feb 21
2022
|
Michael J Landine SVP, Corp Dev., Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
5,825
+2.45%
|
-
|
|
Feb 21
2022
|
Richard F Pops Director and CEO, Alkermes plc |
SELL
Payment of exercise price or tax liability
|
Direct |
14,386
-1.63%
|
$359,650
$25.08 P/Share
|
|
Feb 21
2022
|
Richard F Pops Director and CEO, Alkermes plc |
BUY
Exercise of conversion of derivative security
|
Direct |
32,400
+3.55%
|
-
|
|
Feb 21
2022
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,022
-8.6%
|
$50,550
$25.08 P/Share
|
|
Feb 21
2022
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,875
+22.63%
|
-
|
|
Feb 20
2022
|
Iain Michael Brown SVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,348
-2.55%
|
$33,700
$25.08 P/Share
|
|
Feb 20
2022
|
Iain Michael Brown SVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,589
+7.98%
|
-
|
|
Feb 20
2022
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
2,061
-2.29%
|
$51,525
$25.08 P/Share
|
|
Feb 20
2022
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
7,036
+7.26%
|
-
|
|
Feb 20
2022
|
Blair Curtis Jackson EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,335
-1.69%
|
$33,375
$25.08 P/Share
|
|
Feb 20
2022
|
Blair Curtis Jackson EVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,589
+5.48%
|
-
|
|
Feb 20
2022
|
Michael J Landine SVP, Corp Dev., Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
2,368
-1.04%
|
$59,200
$25.08 P/Share
|
|
Feb 20
2022
|
Michael J Landine SVP, Corp Dev., Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
5,354
+2.29%
|
-
|
|
Feb 20
2022
|
Christian Todd Nichols SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,252
-5.6%
|
$31,300
$25.08 P/Share
|
|
Feb 20
2022
|
Christian Todd Nichols SVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,824
+14.6%
|
-
|
|
Feb 20
2022
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,966
-15.14%
|
$74,150
$25.08 P/Share
|
|
Feb 20
2022
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,096
+34.01%
|
-
|
|
Feb 18
2022
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,306
-19.54%
|
$57,650
$25.17 P/Share
|
|
Feb 16
2022
|
Richard F Pops Director and CEO, Alkermes plc |
SELL
Payment of exercise price or tax liability
|
Direct |
8,038
-0.94%
|
$208,988
$26.79 P/Share
|
|
Feb 16
2022
|
Richard F Pops Director and CEO, Alkermes plc |
BUY
Exercise of conversion of derivative security
|
Direct |
18,125
+2.07%
|
-
|
|
Feb 16
2022
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,098
-1.31%
|
$28,548
$26.79 P/Share
|
|
Feb 16
2022
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
3,375
+3.87%
|
-
|
|
Feb 16
2022
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,069
-8.31%
|
$27,794
$26.79 P/Share
|
|
Feb 16
2022
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,375
+20.77%
|
-
|
|
Feb 16
2022
|
Michael J Landine SVP, Corp Dev., Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,620
-0.72%
|
$42,120
$26.79 P/Share
|
|
Feb 16
2022
|
Michael J Landine SVP, Corp Dev., Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
3,375
+1.48%
|
-
|
|
Feb 16
2022
|
Iain Michael Brown SVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
825
-1.68%
|
$21,450
$26.79 P/Share
|
|
Feb 16
2022
|
Iain Michael Brown SVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,375
+4.61%
|
-
|
|
Feb 16
2022
|
Blair Curtis Jackson EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
825
-1.09%
|
$21,450
$26.79 P/Share
|